NASDAQ

Incannex Healthcare Inc. (IXHL)

331 Thanks from members

Incannex Healthcare Inc. (IXHL) presents a high-risk binary biotech profile, balancing strong Phase 2 results and over $70 million in debt-free cash against severe dilution pressures and a depressed valuation near its 52-week lows.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →